These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 1787392)
1. Commentary: maintaining the somatic/germ-line distinction: some ethical drawbacks. Moseley R J Med Philos; 1991 Dec; 16(6):641-7. PubMed ID: 1787392 [TBL] [Abstract][Full Text] [Related]
2. Ethical issues in manipulating the human germ line. Lappé M J Med Philos; 1991 Dec; 16(6):621-39. PubMed ID: 1787391 [TBL] [Abstract][Full Text] [Related]
3. Genetic disorders and the ethical status of germ-line gene therapy. Berger EM; Gert BM J Med Philos; 1991 Dec; 16(6):667-83. PubMed ID: 1787394 [TBL] [Abstract][Full Text] [Related]
4. Germ-line engineering: a few European voices. Mauron A; Thévoz JM J Med Philos; 1991 Dec; 16(6):649-66. PubMed ID: 1787393 [TBL] [Abstract][Full Text] [Related]
5. Germ-line gene therapy: back to basics. Juengst ET J Med Philos; 1991 Dec; 16(6):587-92. PubMed ID: 1787388 [No Abstract] [Full Text] [Related]
6. Commentary: how do we think about the ethics of human germ-line genetic therapy? Nolan K J Med Philos; 1991 Dec; 16(6):613-9. PubMed ID: 1787390 [TBL] [Abstract][Full Text] [Related]
7. Human gene therapy and slippery slope arguments. McGleenan T J Med Ethics; 1995 Dec; 21(6):350-5. PubMed ID: 8778459 [TBL] [Abstract][Full Text] [Related]
8. What is morally distinctive about genetic engineering? Porter J Hum Gene Ther; 1990; 1(4):419-24. PubMed ID: 2078584 [TBL] [Abstract][Full Text] [Related]
9. Debunking the slippery slope argument against human germ-line gene therapy. Resnik D J Med Philos; 1994 Feb; 19(1):23-40. PubMed ID: 8201288 [TBL] [Abstract][Full Text] [Related]
10. Ethical manipulations: an ethical evaluation of the debate surrounding genetic engineering. van Tongeren PJ Hum Gene Ther; 1991; 2(1):71-5. PubMed ID: 1863642 [TBL] [Abstract][Full Text] [Related]
11. Genetic therapy: ethical and religious reflections. Gustafson JM J Contemp Health Law Policy; 1992; 8():183-200. PubMed ID: 11645738 [No Abstract] [Full Text] [Related]
12. The moral significance of the therapy-enhancement distinction in human genetics. Resnik DB Camb Q Healthc Ethics; 2000; 9(3):365-77. PubMed ID: 10858885 [No Abstract] [Full Text] [Related]
13. Four versions of double effect. Marquis DB J Med Philos; 1991 Oct; 16(5):515-44; discussion 565-70. PubMed ID: 1779210 [TBL] [Abstract][Full Text] [Related]
14. Conceptions of morality and the doctrine of double effect. Nelson WN J Med Philos; 1991 Oct; 16(5):545-64. PubMed ID: 1779211 [TBL] [Abstract][Full Text] [Related]
15. Does human gene therapy raise new ethical questions? Tauer CA Hum Gene Ther; 1990; 1(4):411-8. PubMed ID: 2078583 [TBL] [Abstract][Full Text] [Related]
16. Should we change the human genome? Tännsjö T Theor Med; 1993 Sep; 14(3):231-47. PubMed ID: 8259530 [TBL] [Abstract][Full Text] [Related]
17. Germ-line gene therapy and the medical imperative. Munson R; Davis LH Kennedy Inst Ethics J; 1992 Jun; 2(2):137-58. PubMed ID: 11645742 [TBL] [Abstract][Full Text] [Related]
18. Genetic engineering: moral aspects and control of practice. Eisenberg VH; Schenker JG J Assist Reprod Genet; 1997 Jul; 14(6):297-316. PubMed ID: 9226508 [TBL] [Abstract][Full Text] [Related]
19. Altering human genes: social, ethical, and legal implications. Baird PA Perspect Biol Med; 1994; 37(4):566-75. PubMed ID: 8084741 [No Abstract] [Full Text] [Related]
20. Distinguishing genetics and eugenics on the basis of fairness. Ledley FD J Med Ethics; 1994 Sep; 20(3):157-64. PubMed ID: 7996561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]